Login / Signup

Molecular Breast Imaging of HER2-Positive Breast Cancer in the Era of PHERGain Trial: The past, the Present, and the Prospects.

Luca FilippiMartin W Brechbiel
Published in: Cancer biotherapy & radiopharmaceuticals (2024)
Keyphrases
  • positive breast cancer
  • high resolution
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • current status
  • randomized controlled trial
  • single molecule
  • fluorescence imaging
  • photodynamic therapy